Hydralazine hydrochloride 25 mg / hydrochlorothiazide 15 mg / reserpine 0.1 mg [Ser-Ap-Es]
RxNorm 905366
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 905366 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: hydralazine hydrochloride 25 mg / hydrochlorothiazide 15 mg / reserpine 0.1 mg [Ser-Ap-Es].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDC
Semantic Branded Drug Component (SBDC):
Hydralazine hydrochloride 25 mg / hydrochlorothiazide 15 mg / reserpine 0.1 mg [Ser-Ap-Es]
(Atom ID: 12301762)
TMSY